The bibliography is divided into the following three sections:
I.    19 professional books
II.   34 peer-reviewed articles
III.  Many other professional publications such as articles, reviews, letters, and book chapters.

I. PROFESSIONAL BOOKS
 
1. College Students in a Mental Hospital: Contribution to the Social Rehabilitation of the Mentally Ill.  New York, Grune & Stratton, 1962 (jointly authored by Carter Umbarger, James Dalsimer, Andrew Morrison, and Peter Breggin).  

2. Electroshock: Its Brain-Disabling Effects.  New York, Springer
Publishing Company, 1979.  Translated into French, German &
Italian.  Behavioral Sciences Book Club selection.
 
3. The Psychology of Freedom: Liberty and Love as a Way of Life . 
Buffalo, Prometheus Books, 1980.

4. Psychiatric Drugs: Hazards to the Brain.  New York, Springer
Publishing Company, 1983.

5. Toxic Psychiatry: Why Therapy, Empathy and Love Must Replace the Drugs, Electroshock and Biochemical Theories of the “New Psychiatry"   New York, St. Martin's Press, 1991.  Psychotherapy
Book Club selection.  Special English edition with an introduction by Dorothy Rowe.  Harper/Collins, London, 1993.  St. Martin's paperback, 1994.  Also translated into German.

6. Beyond Conflict: From Self-Help and Psychotherapy to Peacemaking New York, St. Martin's Press (scholarly division), 1992.  St. Martin's paperback, 1995.

7. Talking Back to Prozac (Coauthored by Ginger Breggin) New York: St. Martin's Press, 1994.  St. Martin's Press, 1994.  St. Martin's paperback, 1994.

8. Psychosocial Approaches to Deeply Disturbed Patients. Senior Editor, Peter Breggin. Co-editor, E. Mark Stern.  New York: Haworth Press.  Also published as The Psychotherapy Patient, Volume 9, Numbers 3/4, 1996.

9. The War Against Children: How the Drugs, Programs, and Theories of the Psychiatric Establishment Are Threatening America's Children with a Medical “Cure" for Violence.  Coauthored by Ginger Breggin.  New York, St. Martin's Press, 1994.

10. Brain-Disabling Treatments in Psychiatry.  New York: Springer Publishing Company, 1997.

11. The Heart of Being Helpful: Empathy and the Creation of a Healing Presence.  New York: Springer Publishing Company, 1997.

12. Talking Back to Ritalin.  (first edition) Monroe, Maine: Common Courage Press, 1998.

13. The War Against Children of Color. (revised edition).  Coauthored by Ginger Breggin.  Monroe, Maine: Common Courage Press, 1998.

14.  Your Drug May Be Your Problem: How and Why To Stop Taking Psychiatric Medications.  Co-authored by David Cohen, Ph.D.  Reading, MA: Perseus Books, 1999.

15. Reclaiming Our Children: A Healing Solution for a National In Crisis. Cambridge, MA: Perseus Books, 2000.

16. Talking Back to Ritalin. (revised edition).  Cambridge, MA: Perseus Books, 2000.

17. The Antidepressant Fact Book.  Cambridge, MA: Perseus Books, 2001

18. Dimensions of Empathic Therapy. Co-edited by Ginger Breggin and Fred Bemak, Ed.D.  New York: Springer Publishing Company, 2002.

19. The Ritalin Fact Book. Cambridge, MA: Perseus Books, 2002. 


II. PEER REVIEWED ARTICLES
   
1.    "The Psychophysiology of Anxiety."  Journal of Nervous Mental Diseases 139:558-568, 1964.

2.    "Coercion of Voluntary Patients in an Open Hospital."  Archives of General Psychiatry 10:173-181, 1964.  Reprinted with a new introduction in Edwards, R.B. (ed): Psychiatry and Ethics.  Buffalo, Prometheus Books, 1982, and in Edwards, R.B. (ed): Ethics of Psychiatry. Amherst, New York, Prometheus Books, 1997.
 
3. "The Sedative-like Effect of Epinephrine."  Archives of General Psychiatry  12:255-259, 1965.

4. "Psychotherapy as Applied Ethics."  Psychiatry 34:59-75, 1971.

5. "Therapy As Applied Utopian Politics."  Mental Health and Society 1:129-146, 1974.


6. "Psychiatry and Psychotherapy as Political Processes."  American Journal of Psychotherapy 29:369-382, 1975.

7. "Madness is a Failure of Free Will; Therapy Too Often Encourages It."  Psychiatric Quarterly 53:61-68, 1981.
    Originally published (in French) in Verdiglione A (ed): La Folie Dans La Psychoanalyse.  Paris, Payot, 1977.

8. "Electroshock Therapy and Brain Damage: The Acute Organic Brain Syndrome as Treatment."  Behavior and Brain Sciences 7:24-25, 1984 (commentary).

9. "Neuropathology and Cognitive Dysfunction from ECT."  Psychopharmacology Bulletin  22:476-479, 1986.

10. "Ellettroshock: Tra Rischioiatrogeno e Mito Terapeutico."  (P. Breggin and G. de Girolamo)  Quaderni Italiani di Psychiatrica 6:497-540, 1987.

11. "The Three Dynamics of Human Progress: A Unified Theory Applicable to Individuals, Institutions and Society."  Review of Existential Psychology and Psychiatry 21:(Nos. 1-3)97-123, 1988-89.

12. "Precious the Crow."  Voices (Journal of the American Academy of Psychotherapists) 23:32-42, Summer, 1987.

13. "Brain Damage, Dementia and Persistent Cognitive Dysfunction Associated with Neuroleptic Drugs: Evidence, Etiology, Implications."  Journal of Mind Behavior 11:425-464, 1990.

14. "Psychotherapy in the Shadow of the Psycho-Pharmaceutical Complex," Voices (journal of the American Academy of Psychotherapists)  27:15-21, 1991

15. "A Case of Fluoxetine-induced Stimulant Side Effects with Suicidal Ideation Associated with a Possible Withdrawal Syndrome ("Crashing")."  International Journal of Risk & Safety in Medicine 3:325-328, 1992

16. "Parallels Between Neuroleptic Effects and Lethargic Encephalitis: The Production of Dyskinesias and Cognitive disorders."  Brain and Cognition 23:8-27, 1993.

17. "A Biomedical Programme for Urban Violence Control in the US: The Dangers of Psychiatric Social Control."  (Peter Breggin and Ginger Ross Breggin). Changes: An International Journal of Psychology and Psychotherapy 11, No. 1 (March):59-71, 1993. 

18. "Psychiatry's Role in the Holocaust."  International Journal of Risk and Safety in Medicine 4:133-148, 1993.  Adapted from a paper delivered at "Medical Science Without Compassion" in Cologne, Germany and published in the conference proceedings.

19. "Should the Use of Neuroleptics Be Severely Limited?"  Changes: An International Journal of Psychology and Psychotherapy  14:62-66  March 1996.
   
20. "The Hazards of Treating 'Attention-Deficit/Hyperactivity Disorder' with Methylphenidate (Ritalin)" (Coauthored by Ginger Breggin)  Journal of College Student Psychotherapy 10:55-72, 1996.

21. "Psychotherapy in Emotional Crises without Resort to Psychiatric Medication." The Humanistic Psychologist 25:2-14, 1998.

22. "Analysis of Adverse Behavioral Effects of Benzodiazepines with a Discussion of Drawing Scientific Conclusions from the FDA's Spontaneous Reporting System."  Journal of Mind and Behavior 19:21-50, 1998.

23. "Electroshock: Scientific, ethical, and political issues.”  International Journal of Risk & Safety In Medicine 11:5-40, 1998.

24. "Psychostimulants in the treatment of children diagnosed with ADHD: Part I—Acute risks and psychological effects."  Ethical Human Sciences and Services 1:13-33, 1999.

25. "Psychostimulants in the treatment of children diagnosed with ADHD: Part II—Adverse effects on brain and behavior.”  Ethical Human Sciences and Services 1:213-241, 1999. 

26. "Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action."  International Journal of Risk and Safety in Medicine, 12 (1), 3-35, 1999.
    (Simultaneously published version of #’s 24 and 25)

27. "What psychologists and psychotherapists need to know about ADHD and stimulants."  Changes: An International Journal of Psychology and Psychotherapy 18:13-23,  Spring 2000

28. "The NIMH multimodal study of treatment for attention-deficit/hyperactivity disorder: A critical analysis."  International Journal of Risk and Safety in Medicine 13:15-22, 2000

29. "Empathic self-transformation and love in individual and family therapy."  Humanistic Psychologist, 27:267-282,  1999.

30. "Fluvoxamine as a cause of stimulation, mania, and aggression with a critical analysis of the FDA-approved label."  International Journal of Risk and Safety in Medicine, 2002, in press.

31. “Psychopharmacology and human values.” Journal of Humanistic Psychology, 43: 34-49, 2003.

32. “Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis.” International Journal of Risk and Safety in Medicine, 16: 31-49, 2003/2004. Simultaneously published in Ethical Human Sciences and Services, 5:225-246, 2003.

33. “Recent U.S., Canadian and British regulatory agency actions concerning antidepressant-induced harm to self and others: A review and analysis.” Ethical Human Psychology and Psychiatry, 7, 7-22, 2005. Simultaneously published in the International Journal of Risk and Safety in Medicine, 16, 247-259, 2005.

34. “Recent regulatory changes in antidepressant labels: Implications for activation (stimulation) in clinical practice.” Primary Psychiatry, 13, 57-60.

III. OTHER ARTICLES, REPORTS, LETTERS, AND BOOK CHAPTERS

"Schizophrenia as nondependency."  Hutchings Journal (Department of Psychiatry, State University of New York, Upstate Medical Center, Syracuse).  Vol. l, No. 2, pp. 1-3, December 1962.

"The college student and the mental patient."  In College Student Companion Program: Contribution to the Social Rehabilitation of the Mentally Ill.  Rockville, Maryland; National Institute of Mental Health, 1962.

"The psychophysiology of anxiety applied to the effect of adrenaline on rat behavior."  Submitted in partial fulfillment of the requirements for the degree of Doctor of Medicine, Western Reserve School of Medicine, 1962.  Portions published in the Journal of Nervous and Mental Disease (1964) and the Archives of General Psychiatry (1965) (see list of peer reviewed articles).  
 
"The borderland of criminal justice."  (book review and commentary)  Journal of Nervous and Mental Diseases 141:387-394, 1965.
 
"Lobotomy is still bad medicine."  Medical Opinion 8:3236, 1972.

"Lobotomies: an alert."  (letter)  American Journal of Psychiatry 129:98-99, 1972.
 
"The politics of therapy."  M/H (Mental Health) 56:9-13,1972.

"Lobotomy." (co-authored by Daniel Greenberg).  Science and Government Policy, March 15, 1972, Volume II, No. 2, p. !. 

"Psychosurgery." (letter) Journal of the American Medical Association 226:1121, 1973.
 
"The second wave of psychosurgery."  M/H (Mental Health) 57:10-13, 1973. 
 
"Psychiatric oppression of prisoners."  (coauthored by PL Breggin).   Psychiatric Opinion, June, 1974
 
"Psychosurgery for political purposes." Duquesne Law Review 13:841-862, 1975.
 
"Psychosurgery for the control of violence: a critical review."  Chapter IV in Fields W, Sweet W (eds): Neural  Bases of Violence and Aggression .  St. Louis, Warren H. Green Publisher, 1975.   
 
"If psychosurgery is wrong in principle...?"  Psychiatric Opinion , November/December 1977.

"La seconde vague.  A propos de la lobotomie."  In  Verdiglione A (ed): La Folie II: Actes Due Colloque De Milan, 1976.  Paris, Giangiacomo Feltrinelli, 1977.
 
"Brain-disabling therapies."  In Valenstein E (ed): The Psychosurgery Debate.  San Francisco, WH Freeman, 1980.
 
"Disabling the brain with electroshock."  In Dongier M, Wittkower ED (eds): Divergent Views in Psychiatry. Hagerstown, Maryland; Harper and Row, 1981.
 
"Psychosurgery as brain-disabling therapy."  In Dongier M, Wittkower D (eds): Divergent Views in Psychiatry. Hagerstown, Maryland; Harper and Row, 1981.
 
"Compulsion as a spiritual disorder." (co-authored by J. Kasmir)  Newsletter of the Washington Branch of the Association for Humanistic Psychology .  Washington, D.C., October, 1982.

"The return of lobotomy and psychosurgery."  Reprinted with a new introduction in Edwards RB (ed): Psychiatry and Ethics.  Buffalo, Prometheus Books, 1982.  Originally published in the Congressional Record , February 24, 1972, E1602-E1612.  First reprinted in Quality of Health Care-Human Experimentation: Hearings Before Senator Edward Kennedy's Subcommittee on Health, US Senate, Washington, D.C., US Government Printing Office, 1973.

"Testimony on electroshock treatment" before the Respiratory and Nervous System Devices Panel, Volume II, Food and Drug Administration, Department of Health and Human Services, Washington, DC, November 4, 1982.

"What cost leukotomy?"  (letter)  American Journal of Psychiatry 140:1101, 1983.

"Iatrogenic helplessness in authoritarian psychiatry." In Morgan RF (ed): The Iatrogenics Handbook.  Toronto, IPI Publishing Company, 1983.
 
"Neuropathology and cognitive dysfunction from ECT."  Presented at the Consensus Development Conference on Electroconvulsive Therapy, sponsored by NIMH and NIH, 1985. 
 
"Brain damage from nondominant ECT." (letter)  American Journal Psychiatry 143:1320-1, 1986.

"Workshop on medication."  In CSP: Choices and Challenges.  Proceedings of the Seventh National Conference of the Community Support Program of the National Institute of Mental Health, 1985.  U.S. Department of Health and Human Services, National Institute of Mental Health, Rockville, Maryland 1986, pp. 92-95. 

"Point-Counterpoint: Is electroconvulsive therapy outmoded?" Physicians Weekly  April 21, 1986.
 
"Sex and love: sexual dysfunction as a spiritual disorder."  In Shelp EE (ed): Sexuality and Medicine. Boston, D. Reidel, 1987.
 
"A hierarchy of values for evaluating human progress on an individual, institutional and societal basis," in Kollenda K (ed): Ethical Individualism and Organizations . New York, Praeger, 1988.

"Debate over euthanasia termed reminiscent of pre-Nazi Germany," Clinical Psychiatry News, December 1988.

"Addiction to neuroleptics?"  American Journal of Psychiatry 146:560, 1989

"Addiction to neuroleptics: Dr. Breggin Replies."  American Journal Psychiatry 146:1240, 1989

"The scapegoating of American children."  Rights Tenet,  March, 1990. Reprinted from the Wall Street Journal, November 7, 1989.

"Cingulotomy rightfully abandoned." [letter]  The Psychiatric Times , May 1990, p. 8

"The homeless mentally ill."  (coauthored by M. Weinberger and P. Breggin)  American Journal of Psychiatry 148:600-601, 1991.

"San Francisco Board of Supervisors passes resolution against shock."  Rights Tenet, Spring 1991.   

"More on the California shock controversy."  Rights Tenet, Summer 1991.

"The facts about Clozapine (Clozaril)."  Rights Tenet, Autumn 1991.

"Feminist paradigms and conflict resolution."  (Co-authored by Ginger Ross-Breggin and Peter Breggin).  ICAR Newsletter (Institute for Conflict Analysis and Resolution, George Mason University) Spring 1992.

"The President's sleeping pill and its makers" (letter).  New York Times, February 11, 1992.

"How and why psychiatry became a death machine [in Nazi Germany]."  In Roland, C., Friedlander, H. and Muller-Hill, B. (Eds.): Medical Science Without Compassion.   Arbeitspapiere-Atti-Proceedings.  No. 11.  Hamburger Stiftung fur Sozialgeschichte des 20. Jahrhunderts.  Hamburg, May 1992. 

"The return of ECT." Readings: A Journal of Reviews and Commentary in Mental Health, 3 (March, #1), 12-17, 1992.

"Prozac, suicide and violence: An analysis with reports from the Prozac Survivors Support Group, Inc."  Rights Tenet,  Winter/Spring 1992.

"The 'Violence Initiative'-- A racist biomedical program for social control."  Rights Tenet, Summer 1992.

"U.S. Government asks, 'Are black people genetically violent?'" (co-authored by Ginger Breggin).  Rights Tenet,  Winter/Spring 1992.

"The Federal Violence Initiative: Threats to black children (and others)."  (Coauthored by Ginger Breggin).  Psych Discourse (newsjournal of the Association of Black Psychologists) 24, No. 4 (April):8-11, 1993.

"Psychiatry doesn't cure unhappiness."  (letter) New York Time s, September 11, 1993, p. A20.

"The FDA--More harm than good?"  Rights Tenet, Summer 1993.

"Psychogate: Eli Lilly buys justice for itself."  Rights Tenet , Autumn 1993.

"Children First." Rights Tenet, Winter 1993-94.

"Talking back to Prozac." Psychology Today, July/August 1994, p. 46.

"Prozac story misleading."  (letter) APA Monitor (Newspaper of the American Psychological Association), July 1994, p. 3-4

"Should the use of neuroleptics be severely limited? Yes."  In S. A. Kirk and Susan D. Einbinder P (ed): Controversial Issues in Mental Health .  Boston: Allyan and Bacon, 1994, pp. 146-152.

"Let's not 'treat' the problem of homelessness with drugs."  (letter)  New York Times, June 28, 1994, p. A16

"Genetics and crime: Violence and the danger of psychiatric social control."  (Coauthored by Ginger Ross Breggin).  21st Century Afro Review , Fall 1994, pp. 41-62. 

"The Federal Violence Initiative comes to Chicago." Rights Tenet , Spring 1994.

"Talking back to Prozac."  Rights Tenet, Summer 1994.

"Joe McCarthy lives!" [About the PR tactics of Eli Lilly]  Rights Tenet, Autumn 1994

"Encephalitis Lethargica."  [letter].  Journal of Neuropsychiatry , 7 (3), p. 387, summer 1995.

"Prozac 'hazardous' to children."  (letter)  Clinical Psychiatry News, September 1995, p. 11

"Drugging our children won't cure the problems in schools."  Insight [magazine of the Washington Times]  August 14, 1995, p. 18-21.

"Psychiatry doesn't help mental health cause."  (letter)  New York Times, March 9, 1995, p. A24

"On the couch, culture affects all."  (letter) New York Times , December 8, 1995, p. A30

"Future development of neuroleptic medications: A report to the FDA."  Rights Tenet, Fall 1995

"Campaigns against racist federal programs by the Center for the Study of Psychiatry and Psychology."  Journal of African American Men 1:No. 3, 3-22.  Winter 1995/96.

"Prescription privileges." (letter) APA Monitor (newspaper of the American Psychological Association), March 1996, p. 49.
 
"The FDA was agitated over Halcion." (letter).  Business Week , July 18, 1996.

"Shock treatment III: Resistance in the 1980s."  Chapter 4 in Morgan R (Ed): Electric Shock.  Toronto, IPI Publishing, 1985.  Republished in Morgan R (Ed): Electroshock: The Case Against.  Morgan Foundation Publishing: International Published Innovations, Greenville, CA 1997

"Spearheading a transformation." Introduction to P. Breggin & E. M. Stern (eds): Psychosocial Approaches to Deeply Disturbed Patients .  New York: Haworth Press, 1996.

"Whose attention disorder does Ritalin treat?"  (letter).  New York Times, May 20, 1996, p. A14.

"Talking back to Eli Lilly."  [Guest Commentary]  Sacramento News & Review, June 13, 1996

"No, don't relax ban" [critique of new FDA rules permitting involuntary medical experimentation]. (letter).  New York Times, November 6, 1996, p. A6.

Psychotherapy in emotional crises without resort to psychiatric medication." The Humanistic Psychologist, 25, 2-14, 1998.

"Neuroleptic warning" [in regard to clozapine-induced brain damage in children]. (letter) Clinical Psychiatry News, March 1998, p. 8.

"Recent FDA decision raises ethical issues in drug research on children."  ICSPP News (International Center for the Study of Psychiatry and Psychology), Spring/Summer, 1998, p. 3.

"Upcoming government conference on ADHD and Psychostimulants asks wrong questions." ICSPP News (International Center for the Study of Psychiatry and Psychology), Spring/Summer, 1998, p. 4.

"Background paper: Details revealed about dangerous federally funded NYC experiments on children." [No byline] ICSPP News (International Center for the Study of Psychiatry and Psychology), Spring/Summer, 1998, p. 13.

"Does clozapine treatment cause brain damage?" (1998, September) (letter) Archives of General Psychiatry 55:845.

"Risks and mechanism of action of stimulants."  (1998)  In NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: Program and Abstracts, pp. 105-12.  Rockville, MD: National Institutes of Health.  

"Interview with Peter R. Breggin, M.D., author of Talking Back to Ritalin."  Corporate Crime Reporter, 12 (16), April 20, 1998.

"Psychostimulant effects on children: A primer for school psychologists and counselors." (1998, December) Communique' (Newspaper of NASP--National Association of School Psychologists), pp. 8-9.

"To love them is to drug them?" (February, 1999).  Dr. Laura Perspective [magazine published by Dr. Laura Schlessinger], pp. 8-9, ff.

"Foreword" in Stein, D.B. (1999). Ritalin is not the answer.  San Francisco, Jossey-Bass, pp. ix-xii.

"Foreword" in Vontress, C.E., Johnson, J.A., and Epp, L.R. (1999). Cross-cultural counseling: A case book.  Alexandria, Virginia,  American Counseling Association, pp. xi-xii.

"Prozac pedagogy." (letter).  California Lawyer, March 15, 1999, p. 15

"Breaking news that Eric Harris was taking Luvox at the time of the Littleton Murders."  Press Release. International Center for the Study of Psychiatry and Psychology, Bethesda, Maryland, April 30, 1999..

"Treatment of attention-deficit/hyperactivity disorder."  (1999, April 28). [letter]  Vol. 281, No. 16. Journal of the American Medical Association, pp. 1490-1.

"From the editor-in-chief: The need for 'ethical' human sciences and services." (1999, spring.) Ethical Human Sciences and Services, 1, 3-6.

"NIH consensus report highlights controversy surrounding ADHD diagnosis and stimulant treatment." (1999, spring). Unsigned news commentary.  Ethical Human Sciences and Services, 1, 9-11.

"National Institute of Mental Health fails in its latest effort to push Ritalin on America's children."  Unsigned report from ICSPP.  The Rights Tenet (Summer 1999), pp. 4-5.

"Your drug may be your problem." Commentary.  Washington Times , Sunday, October 24, 1999, p. B5.

"Don't let 'experts' parent your children."  Op Ed Column.  USA Today.  Monday,  February 28, 2000, p. 19A..

"A critical analysis of the NIMH multimodal treatment study for Attention-Deficit Hyperactivity Disorder (the MTA study)."  Ethical Human Sciences and Services, 2, 63-72, 2000.

"A dangerous assignment."  In Howard Rosenthal (Ed.). Favorite Counseling and Therapy Homework Assignments: Leading Therapist Shares their Most Creative Strategies, pp. 58-59.   Philadelphia: Brunner Routledge, 2001.

"Neurotoxicants threaten childhood development."  (letter).  Psychiatric Times, July 2001, p. 8.

"Confirming the hazards of stimulant drug treatment."  (2001) Guest editorial.  International Journal of Risk & Safety in Medicine , 17, 199-200.

"Psychiatry's reliance on coercion."  (2000) Editorial.  Ethical Human Sciences and Services. 2:115-118.

"Empowering social work in the era of biological psychiatry." (2001) The Ephraim Lisansky lecture of the University of Maryland School of Social Work.  Ethical Human Sciences and Services. 3:197-206.

"MTA study [NIMH clinical trials on stimulants for ADHD] has flaws."  (letter) (2001) Archives of General Psychiatry, 58, 1184.